1. Home
  2. HTO vs DYN Comparison

HTO vs DYN Comparison

Compare HTO & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTO
  • DYN
  • Stock Information
  • Founded
  • HTO 1985
  • DYN 1984
  • Country
  • HTO United States
  • DYN United States
  • Employees
  • HTO N/A
  • DYN N/A
  • Industry
  • HTO Water Supply
  • DYN Medicinal Chemicals and Botanical Products
  • Sector
  • HTO Utilities
  • DYN Health Care
  • Exchange
  • HTO Nasdaq
  • DYN Nasdaq
  • Market Cap
  • HTO 1.8B
  • DYN 1.9B
  • IPO Year
  • HTO N/A
  • DYN 2020
  • Fundamental
  • Price
  • HTO $47.13
  • DYN $13.06
  • Analyst Decision
  • HTO Hold
  • DYN Strong Buy
  • Analyst Count
  • HTO 1
  • DYN 14
  • Target Price
  • HTO $58.00
  • DYN $34.93
  • AVG Volume (30 Days)
  • HTO 238.5K
  • DYN 2.4M
  • Earning Date
  • HTO 10-27-2025
  • DYN 11-11-2025
  • Dividend Yield
  • HTO 3.56%
  • DYN N/A
  • EPS Growth
  • HTO 12.08
  • DYN N/A
  • EPS
  • HTO 3.05
  • DYN N/A
  • Revenue
  • HTO $788,737,000.00
  • DYN N/A
  • Revenue This Year
  • HTO $8.17
  • DYN N/A
  • Revenue Next Year
  • HTO $6.15
  • DYN N/A
  • P/E Ratio
  • HTO $15.47
  • DYN N/A
  • Revenue Growth
  • HTO 12.40
  • DYN N/A
  • 52 Week Low
  • HTO $44.91
  • DYN $6.36
  • 52 Week High
  • HTO $60.56
  • DYN $35.90
  • Technical
  • Relative Strength Index (RSI)
  • HTO 38.25
  • DYN 52.74
  • Support Level
  • HTO $46.46
  • DYN $12.33
  • Resistance Level
  • HTO $48.89
  • DYN $13.07
  • Average True Range (ATR)
  • HTO 0.95
  • DYN 0.70
  • MACD
  • HTO -0.15
  • DYN -0.12
  • Stochastic Oscillator
  • HTO 23.76
  • DYN 55.34

About HTO H2O America Common Stock

H2O America is a national investor-owned network of local water and wastewater utilities united by one purpose: delivering clean, high-quality water to the communities it calls home. Across approximately 407,000 water and wastewater service connections, the company invests in critical infrastructure to strengthen the water supply for generations to come.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: